Fichas
Short-acting insulin (actrapid)
Fichas del conjunto (8)
- 1IndicationsType 1 diabetes
Type 2 diabetes inadequately controlled with diet, exercise and oral antidiabetic drugs, and where oral antidiabetic drugs cannot be used - 2ActionsIncrease or restore ability to metabolise glucose by enhancing cellular glucose uptake
inhibit endogenous glucose output and lipolysis. - 3Pharmacokinetics (absorption)Well absorbed from subcutaneous abdominal injection sites, not as well absorbed in other sites
- 4Pharmacokinetics (distribution)Does not enter breast milk or cross the placenta
- 5Metabolism & excretionMostly metabolised by the liver, with the remained excreted by the kidneys. Also metabolised at a cellular level.
- 6InteractionsCaution should be used when taking other drugs that decrease glucose levels in the blood such as MAOIs, betablockers, salicylates or alcohol. Dose should be adjusted accordingly.
- 7Nursing assessment requirementsBGL level pre and post
Baseline vital signs to assist with detecting hypo/hyperglycaemia
Monitor person's response to administration - 8EducationDiabetes education: signs of hypoglycaemia, diet, exercise. Consider referral to diabetes education.
Información
- Descripción
- El usuario ha eliminado su información de asignaturas Fichas sobre Short-acting insulin (actrapid), creado por Usuario eliminado el 03/06/2018.
- Creado por
- Usuario eliminado · jun 2018
- Actualizado
- 3 jun 2018
- Visitas
- 12
- Historial
-
- Creado por Em J · 3 jun 2018
- Copiado por Em J · 3 jun 2018
- Valoración